Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extra-fine HFA-BDP for small airways inflammation in COPD
NCT00921921Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Jun 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of beclomethasone dipropionate in chronic obstructive pulmonary disease (COPD), sponsored by University of Dundee. Primary endpoint: Alveolar Nitric Oxide at 6 weeks. Started Jun 2009; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00921921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00921921.